TCR activation mimics CD127lowPD-1high phenotype and functional alterations of T lymphocytes from septic shock patients

Abstract

Background Sepsis is the leading cause of mortality for critically ill patients worldwide. Patients develop T lymphocyte dysfunctions leading to T-cell exhaustion associated with increased risk of death. As interleukin-7 (IL-7) is currently tested in clinical trials to reverse these dysfunctions, it is important to evaluate the expression of its specific CD127 receptor on the T-cell surface of patients with septic shock. Moreover, the CD127 low PD-1 high phenotype has been proposed as a T-cell exhaustion marker in chronic viral infections but has never been evaluated in sepsis. The objective of this study was first to evaluate CD127 and CD127 low PD-1 high phenotype in septic shock in parallel with functional T-cell alterations. Second, we aimed to reproduce septic shock–induced T-cell alterations in an ex vivo model. Methods CD127 expression was followed at the protein and mRNA levels in patients with septic shock and healthy volunteers. CD127 low PD-1 high phenotype was also evaluated in parallel with T-cell functional alterations after ex vivo activation. To reproduce T-cell alterations observed in patients, purified T cells from healthy volunteers were activated ex vivo and their phenotype and function were evaluated. Results In patients, neither CD127 expression nor its corresponding mRNA transcript level was modified compared with normal values. However, the percentage of CD127 low PD-1 high T cells was increased while T cells also presented functional alterations. CD127 low PD-1 high T cells co-expressed HLA-DR, an activation marker, suggesting a role for T-cell activation in the development of this phenotype. Indeed, T-cell receptor (TCR) activation of normal T lymphocytes ex vivo reproduced the increase of CD127 low PD-1 high T cells and functional alterations following a second stimulation, as observed in patients. Finally, in this model, as observed in patients, IL-7 could improve T-cell proliferation. Conclusions The proportion of CD127 low PD-1 high T cells in patients was increased compared with healthy volunteers, although no global CD127 regulation was observed. Our results suggest that TCR activation participates in the occurrence of this T-cell population and in the development of T-cell alterations in septic shock. Furthermore, we provide an ex vivo model for the investigation of the pathophysiology of sepsis-induced T-cell immunosuppression and the testing of innovative immunostimulant t...

Prognostic factors for ARDS: clinical, physiological and atypical immunodeficiency

“…Although the clinical scores, such as APACHE II [25], SOFA [26] and the PaO 2 /FiO 2 ratio [27], have been widely used to predict the results of clinical practice patients of ARDS. We further found that the lymphocyte/ neutrophil ratio AUC was higher than the PaO 2 /FiO 2 ratio, BMI, APACHE II score, and SOFA score alone in predicting 100-day survival in ARDS patients.…”

Prognostic factors for ARDS: clinical, physiological and atypical immunodeficiency

“…Although clinical scores, such as APACHE II [26], SOFA [27] and the PaO 2 /FiO 2 ratio [28], have been widely used in clinical practice to predict outcome in ARDS patients, we further found that the lymphocyte/neutrophil ratio AUC for predicting 100-day survival in ARDS patients was higher than that for the PaO 2 /FiO 2 ratio, BMI, APACHE II score, and SOFA score alone. The lymphocyte/neutrophil ratio in combination with the lymphocyte count slightly increased the AUC for predicting 100-day survival, yet there was no difference compared with the lymphocyte/neutrophil ratio alone.…”

Analyzing the potential therapeutic mechanism of Huashi Baidu Decoction on severe COVID-19 through integrating network pharmacological methods

“…T cell receptor activation would affect the occurrence of T-cell population and the development of T-cell alterations in septic shock. 30 Therefore, it can be concluded that HSBD might exert its therapeutic effects on severe COVID-19 by inhibiting the pathogens-induced inflammatory response and regulating the immune function of T cells. This conclusion was consistent with the results of GO_BiologicalProcess enrichment.…”